Cortactin Overexpression Results in Sustained Epidermal Growth Factor Receptor Signaling by Preventing Ligand-induced Receptor Degradation in Human Carcinoma Cells

Overview

Journal Breast Cancer Res

Specialty Oncology

Date 2005 Nov 11

PMID 16280034

Citations 5

Authors

Agnes G S H van Rossum

Johan Gibcus

Jacqueline van der Wal

Ed Schuuring

Affiliations

Soon will be listed here.

Abstract

The chromosome 11q13 region is frequently amplified in human carcinomas and results in an increased expression of various genes including cortactin, and is also associated with an increased invasive potential. Cortactin acts as an important regulator of the actin cytoskeleton. It is therefore very tempting to speculate that cortactin is the crucial gene within the 11q13 amplicon that mediates the invasive potential of these carcinomas. Cortactin also participates in receptor-mediated endocytosis, and recent findings have shown that, during receptor internalization, cortactin overexpression inhibits the ubiquitylation-mediated degradation of the epidermal growth factor receptor, resulting in a sustained ligand-induced epidermal growth factor receptor activity.

Citing Articles

Novel CD44-downstream signaling pathways mediating breast tumor invasion.

Ouhtit A, Rizeq B, Abou Saleh H, Rahman M, Zayed H Int J Biol Sci. 2018; 14(13):1782-1790.

PMID: 30443182 PMC: 6231220. DOI: 10.7150/ijbs.23586.

Stanicka J, Rieger L, OShea S, Cox O, Coleman M, OFlanagan C Oncogene. 2018; 37(23):3131-3150.

PMID: 29540831 DOI: 10.1038/s41388-017-0113-z.

Association between genetic polymorphisms in cortactin and susceptibility to gastric cancer.

Kim D, Lee J, Kim K, Kang D, Park W, Cheon Chae S Ann Surg Treat Res. 2015; 89(2):74-80.

PMID: 26236696 PMC: 4518033. DOI: 10.4174/astr.2015.89.2.74.

Strategies to promote translational research within the European Organisation for Research and Treatment of Cancer (EORTC) Head and Neck Cancer Group: a report from the Translational Research Subcommittee.

Psyrri A, Licitra L, Lacombe D, Schuuring E, Budach W, Ozsahin M Ann Oncol. 2010; 21(10):1952-1960.

PMID: 20305037 PMC: 2946861. DOI: 10.1093/annonc/mdq060.

Cortactin expression predicts poor survival in laryngeal carcinoma.

Gibcus J, Mastik M, Menkema L, de Bock G, Kluin P, Schuuring E Br J Cancer. 2008; 98(5):950-5.

PMID: 18268491 PMC: 2266851. DOI: 10.1038/sj.bjc.6604246.

References

Ormandy C, Musgrove E, Hui R, Daly R, Sutherland R . Cyclin D1, EMS1 and 11q13 amplification in breast cancer. Breast Cancer Res Treat. 2003; 78(3):323-35. DOI: 10.1023/a:1023033708204. View

Bao J, Gur G, Yarden Y . Src promotes destruction of c-Cbl: implications for oncogenic synergy between Src and growth factor receptors. Proc Natl Acad Sci U S A. 2003; 100(5):2438-43. PMC: 151359. DOI: 10.1073/pnas.0437945100. View

Wu W, Tu S, Cerione R . Activated Cdc42 sequesters c-Cbl and prevents EGF receptor degradation. Cell. 2003; 114(6):715-25. DOI: 10.1016/s0092-8674(03)00688-3. View

van Rossum A, de Graaf J, Schuuring-Scholtes E, Kluin P, Fan Y, Zhan X . Alternative splicing of the actin binding domain of human cortactin affects cell migration. J Biol Chem. 2003; 278(46):45672-9. DOI: 10.1074/jbc.M306688200. View

Marmor M, Yarden Y . Role of protein ubiquitylation in regulating endocytosis of receptor tyrosine kinases. Oncogene. 2004; 23(11):2057-70. DOI: 10.1038/sj.onc.1207390. View

Daly R . Cortactin signalling and dynamic actin networks. Biochem J. 2004; 382(Pt 1):13-25. PMC: 1133910. DOI: 10.1042/BJ20040737. View

Schuuring E, Verhoeven E, Mooi W, Michalides R . Identification and cloning of two overexpressed genes, U21B31/PRAD1 and EMS1, within the amplified chromosome 11q13 region in human carcinomas. Oncogene. 1992; 7(2):355-61. View

Schuuring E, Verhoeven E, van Tinteren H, Peterse J, Nunnink B, Thunnissen F . Amplification of genes within the chromosome 11q13 region is indicative of poor prognosis in patients with operable breast cancer. Cancer Res. 1992; 52(19):5229-34. View

Schuuring E, Verhoeven E, Litvinov S, Michalides R . The product of the EMS1 gene, amplified and overexpressed in human carcinomas, is homologous to a v-src substrate and is located in cell-substratum contact sites. Mol Cell Biol. 1993; 13(5):2891-98. PMC: 359682. DOI: 10.1128/mcb.13.5.2891-2898.1993. View

10.

Schuuring E . The involvement of the chromosome 11q13 region in human malignancies: cyclin D1 and EMS1 are two new candidate oncogenes--a review. Gene. 1995; 159(1):83-96. DOI: 10.1016/0378-1119(94)00562-7. View

11.

Huang C, Liu J, Haudenschild C, Zhan X . The role of tyrosine phosphorylation of cortactin in the locomotion of endothelial cells. J Biol Chem. 1998; 273(40):25770-6. DOI: 10.1074/jbc.273.40.25770. View

12.

Bowden E, Barth M, Thomas D, Glazer R, Mueller S . An invasion-related complex of cortactin, paxillin and PKCmu associates with invadopodia at sites of extracellular matrix degradation. Oncogene. 1999; 18(31):4440-9. DOI: 10.1038/sj.onc.1202827. View

13.

Sauvonnet N, Dujeancourt A, Dautry-Varsat A . Cortactin and dynamin are required for the clathrin-independent endocytosis of gammac cytokine receptor. J Cell Biol. 2004; 168(1):155-63. PMC: 2171671. DOI: 10.1083/jcb.200406174. View

14.

Lua B, Low B . Cortactin phosphorylation as a switch for actin cytoskeletal network and cell dynamics control. FEBS Lett. 2005; 579(3):577-85. DOI: 10.1016/j.febslet.2004.12.055. View

15.

Le Roy C, Wrana J . Clathrin- and non-clathrin-mediated endocytic regulation of cell signalling. Nat Rev Mol Cell Biol. 2005; 6(2):112-26. DOI: 10.1038/nrm1571. View

16.

Zhu J, Zhou K, Hao J, Liu J, Smith N, Zhan X . Regulation of cortactin/dynamin interaction by actin polymerization during the fission of clathrin-coated pits. J Cell Sci. 2005; 118(Pt 4):807-17. DOI: 10.1242/jcs.01668. View

17.

van Rossum A, Schuuring-Scholtes E, van Buuren-van Seggelen V, Kluin P, Schuuring E . Comparative genome analysis of cortactin and HS1: the significance of the F-actin binding repeat domain. BMC Genomics. 2005; 6:15. PMC: 554100. DOI: 10.1186/1471-2164-6-15. View

18.

Timpson P, Lynch D, Schramek D, Walker F, Daly R . Cortactin overexpression inhibits ligand-induced down-regulation of the epidermal growth factor receptor. Cancer Res. 2005; 65(8):3273-80. DOI: 10.1158/0008-5472.CAN-04-2118. View

19.

Merrifield C, Perrais D, Zenisek D . Coupling between clathrin-coated-pit invagination, cortactin recruitment, and membrane scission observed in live cells. Cell. 2005; 121(4):593-606. DOI: 10.1016/j.cell.2005.03.015. View

20.

McNiven M, Kim L, Krueger E, Orth J, Cao H, Wong T . Regulated interactions between dynamin and the actin-binding protein cortactin modulate cell shape. J Cell Biol. 2000; 151(1):187-98. PMC: 2189798. DOI: 10.1083/jcb.151.1.187. View